AstraZeneca Reports a Robust 7% Revenue Growth to $13.6 Billion in Q1 2025

AstraZeneca PLC has announced a 7% increase in Q1 revenue for 2025, reaching $13.6 billion, showcasing its strong performance in the pharmaceutical industry.